Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 34, Issue 4, 2006, Pages 487-495

  Gao, Li ^b   Grant, Audrey ^b   Halder, Indrani ^b   Brower, Roy ^b   Sevransky, Jonathan ^b   Maloney, James P ^b   Moss, Marc ^b   Shanholtz, Carl ^b   Yates, Charles R ^b   Meduri, Gianfranco Umberto ^b   Shriver, Mark D ^b   Ingersoll, Roxann ^b   Scott, Alan F ^b   Beaty, Terri H ^b   Moitra, Jaideep ^b   Ma, Shwu Fan ^b   Ye, Shui Q ^b   Barnes, Kathleen C ^b   Garcia, Joe G N ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

ALI; Genetic association; MYLK MLCK; Sepsis; SNP

Indexed keywords

MYOSIN LIGHT CHAIN KINASE;

ADULT; AFRICAN AMERICAN; AGED; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CASE CONTROL STUDY; CONTROLLED STUDY; EUROPEAN AMERICAN; EXON; FEMALE; GENE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INFLAMMATION; INTRON; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MYLK GENE; PHENOTYPE; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; START CODON;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MYOSIN-LIGHT-CHAIN KINASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK; SEPSIS;

EID: 33645655295     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0404OC     Document Type: Article

References (49)

1. Frutos-Vivar F, Nin N, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care 2004;10:1-6.
2. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005;11:43-49.
3. Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979-1996). Crit Care Med 2002;30:1679-1685.
4. O'Keefe GE, Hybki DL, Munford RS. The G→A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002;52:817-825.
5. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002;30:969-973.
6. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-650.
7. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000;58:181-191.
8. Wang G, Christensen ND, Wigdahl B, Guttentag SH, Floros J. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease. Biochem J 2003;369:179-184.
9. Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 2004;125:203-211.
10. Potier MC, Chelot E, Pekarsky Y, Gardiner K, Rossier J, Turnell WG. The human myosin light chain kinase (MLCK) from hippocampus: cloning, sequencing, expression, and localization to 3qcen-q21. Genomics 1995;29:562-570.
11. Garcia JG, Lazar V, Patterson CE, Gallagher PJ, Verin AD. Endothelial cell myosin light chain kinase: cloning and regulation. Am J Respir Cell Mol Biol 1997;16:487-491.
12. Lazar VL, Garcia JGN. A single human myosin light chain kinase gene transcribes multiple non-muscle isoforms. Genomics 1999;57:256-267.
13. Watterson DM, Schavocky JP, Guo L, Weiss C, Chlenski A, Shirinsky VP, Van Eldik LJ, Haiech J. Analysis of the kinase-related protein gene found at human chromosome 3q21 in a multi-gene cluster: organization, expression, alternative splicing, and polymorphic marker J. Cell Biochem 1999;75:481-491.
14. Brand-Arpon V, Rouquier S, Massa H, de Jong PJ, Ferraz C, Ioannou PA, Demaille JG, Trask BJ, Giorgi D. A genomic region encompassing a cluster of olfactory receptor genes and a myosin light chain kinase (MLCK) gene is duplicated on human chromosome regions 3q13-q21 and 3p13. Genomics 1999;56:98-110.
15. Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell myosin light chain phosphorylation: role in thrombin-induced barrier dysfunction. J Cell Physiol 1995;163:510-522.
16. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-1500.
17. Garcia JGN, Herenyiova M, Cui Y, Verin AD, English D. Activation of endothelial cell myosin light chain kinase by adherent neutrophils: role in transendothelial migration. J Appl Physiol 1998;84:1817-1821.
18. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;280:L1168-L1178.
19. Parker JC. Inhibitors of myosin light chain kinase and phosphodiesterase reduce ventilator-induced lung injury. J Appl Physiol 2000;89:2241-2248.
20. Wainwright MS, Rossi J, Schavocky J, Crawford S, Steinhorn D, Velentza AV, Zasadzki M, Shirinsky V, Jia Y, Haiech J, et al. Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci USA 2003;100:6233-6238.
21. Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell CR, Heiner C, Kent SB, Hood LE. Fluorescence detection in automated DNA sequence analysis. Nature 1986;321:674-679.
22. McCombie WR, Heiner C, Kelley JM, Fitzgerald MG, Gocayne JD. Rapid and reliable fluorescent cycle sequencing of double-stranded templates. DNA Seq 1992;2:289-296.
23. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824.
24. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
26. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999;65:220-228.
27. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
28. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork NJ. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001;11:143-151.
29. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
30. Verin AD, Gilbert-McClain LI, Patterson CE, Garcia JGN. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol 1998;19:767-776.
31. Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science 1999;283:2083-2085.
32. Goeckeler ZM, Masaracchia RA, Zeng Q, Chew TL, Gallagher P, Wysolmerski RB. Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 2000;275:18366-18374.
33. src. J Biol Chem 2001;276:8567-8573.
34. Birukov KG, Birukova AA, Dudek SM, Verin AD, Crow MT, Zhan X, DePaola N, Garcia JG. Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells. Am J Respir Cell Mol Biol 2002;26:453-464.
35. Linz-McGillem LA, Moitra J, Garcia JG. Cytoskeletal rearrangement and caspase activation in sphingosine 1-phosphate-induced lung capillary tube formation. Stem Cells Dev 2004;13:496-508.
36. Petrache I, Birukov K, Zaiman AL, Crow MT, Deng H, Wadgaonkar R, Romer LH, Garcia JGN. Caspase-dependent cleavage of myosin light chain kinase (MLCK) is involved in TNF-α-mediated bovine pulmonary endothelial cell apoptosis. FASEB J 2003;17:407-416.
37. Wadgaonkar R, Linz-McGillem L, Zaiman AL, Garcia JG. Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity. J Cell Biochem 2005;94:351-364.
38. Hurst V, Goldberg PL, Minnear FL, Heimark RL, Vinvcent PA. Rearrangement of adherens junctions by transforming growth factor B1- role of contraction. Am J Physiol 1999;276:L582-L595.
39. Yuan SY, Wu MH, Ustinova EE, Guo M, Tinsley JH, De Lanerolle P, Xu W. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res 2002;90:1214-1221.
40. Khimenko PL, Moore TM, Wilson PS, Taylor AE. Role of calmodulin and myosin light-chain kinase in lung ischemia-reperfusion injury. Am J Physiol 1996;271:L121.
41. Vineis P, McMichael AJ. Bias and confounding in molecular epidemiological studies: special considerations. Carcinogenesis 1998;19:2063-2067.
42. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301.
43. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2005; [Epub ahead of print].
44. Wadgaonkar R, Dudek SM, Zaiman AL, Linz-McGillem L, Verin AD, Nurmukhambetova S, Romer LH, Garcia J G. Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium. J Cell Biochem 2005;95:849-858.
45. Shriver MD, Parra EJ, Dios S, Bonilla C, Norton H, Jovel C, Pfaff C, Jones C, Massac A, Cameron N, et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 2003;112:387-399.
46. Collins-Schramm HE, Chima B, Operario DJ, Criswell LA, Seldin MF. Markers informative for ancestry demonstrate consistent megabase-length linkage disequilibrium in the African American population. Hum Genet 2003;113:211-219.
47. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-1079.
48. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P. Association mapping in structured populations. Am J Hum Genet 2000;67:170-181.
49. Kittles RA, Weiss KM. Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet 2003;4:33-67.